291P HER2-low metastatic breast cancer (MBC): Management and prognosis of a new breast cancer entity in a real-world setting

Authors :: Isabelle Desmoulins
Thomas Bachelot
Anne Patsouris
Christelle Jouannaud
Amélie Lusque
M. Leheurteur
Audrey Mailliez
J-M Ferrero
Lionel Uwer
J-S. Frenel
Suzette Delaloge
A. Gonçalves
Thierry Petit
Paul-Henri Cottu
C. Levy
M.A. Mouret Reynier
Véronique Diéras
Véronique D'Hondt
O. Villacroux
O. De Calbiac
Source :: Annals of Oncology. 32:S491
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
Breast cancer
business.industry
Internal medicine
medicine
Hematology
medicine.disease
business
Metastatic breast cancer

Full Text Access

Tools